Cornerstone Capital Management Holdings’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$77.7M Sell
803,096
-77,457
-9% -$7.3M 0.54% 28
2017
Q3
$78.2M Sell
880,553
-72,986
-8% -$5.56M 0.61% 27
2017
Q2
$69.1M Buy
953,539
+126,435
+15% +$8.5M 0.54% 27
2017
Q1
$53.9M Sell
827,104
-54,794
-6% -$3.44M 0.42% 40
2016
Q4
$55.2M Buy
881,898
+115,445
+15% +$7.05M 0.43% 36
2016
Q3
$48.3M Buy
766,453
+202,879
+36% +$13.1M 0.36% 40
2016
Q2
$34.9M Sell
563,574
-157,703
-22% -$9.61M 0.28% 54
2016
Q1
$41.2M Sell
721,277
-77,244
-10% -$4.31M 0.34% 43
2015
Q4
$47.3M Buy
798,521
+291,761
+58% +$16.8M 0.39% 40
2015
Q3
$27.6M Buy
506,760
+38,037
+8% +$2.48M 0.26% 67
2015
Q2
$31.5M Sell
468,723
-69,436
-13% -$4.53M 0.28% 59
2015
Q1
$31.5M Buy
538,159
+125,469
+30% +$7.58M 0.29% 53
2014
Q4
$27M Buy
412,690
+38,137
+10% +$2.4M 0.28% 72
2014
Q3
$21.6M Sell
374,553
-266,775
-42% -$14.8M 0.23% 98
2014
Q2
$36.2M Buy
641,328
+29,521
+5% +$1.55M 0.4% 44
2014
Q1
$31.4M Buy
611,807
+29,376
+5% +$1.48M 0.37% 50
2013
Q4
$30.8M Sell
582,431
-28,585
-5% -$1.4M 0.35% 52
2013
Q3
$27.3M Sell
611,016
-8,749
-1% -$388K 0.33% 54
2013
Q2
$25.6M Buy
+619,765
New +$27.1M 0.32% 59

Other funds holding ABBV

Cornerstone Capital Management Holdings's ABBV Position: Q4 2017 in Review

Cornerstone Capital Management Holdings reduced its AbbVie (ABBV) stake by 8.8% in Q4 2017, selling an estimated $7.3M and leaving 803,096 shares worth $77.7M. The position accounts for 0.54% of the portfolio, ranked #28.

Cornerstone Capital Management Holdings first reported a position in ABBV in Q2 2013 and has held it in 19 quarters since. The position peaked at $78.2M in Q3 2017. 2,000 funds tracked by Wall St. Rank hold ABBV as of Q4 2017.

  • Cornerstone Capital Management Holdings held 803,096 shares of AbbVie worth $77.7M as of Q4 2017.
  • Cornerstone Capital Management Holdings sold 77,457 AbbVie shares in Q4 2017, an estimated $7.3M.
  • AbbVie made up 0.54% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #28 holding.
  • Cornerstone Capital Management Holdings first reported a position in AbbVie in Q2 2013 and has held it in 19 quarters since.
  • Cornerstone Capital Management Holdings's AbbVie position peaked at $78.2M in Q3 2017.
  • 2,000 funds tracked by Wall St. Rank held AbbVie as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.